Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals

Journal of Viral Hepatitis

Volumn 17, Issue 8, 2010, Pages 588-597

  Martin, C M ^a   Welge, J A ^a   Shire, N J ^a   Rouster, S D ^a   Shata, M T ^a   Sherman, K E ^a   Blackard, J T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

diversity; HBV polymerase; HBV HIV co infection; hepatitis B surface antigen; occult hepatitis B virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RNA DIRECTED DNA POLYMERASE; VIRUS DNA; VIRUS PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; CHEMISTRY; COHORT ANALYSIS; COMPLICATION; DNA SEQUENCE; GENETICS; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PHYLOGENY; PILOT STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SEQUENCE ALIGNMENT; VIROLOGY; YOUNG ADULT;

ADULT; BASE SEQUENCE; COHORT STUDIES; DNA, VIRAL; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV; HIV INFECTIONS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA-DIRECTED DNA POLYMERASE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIRAL STRUCTURAL PROTEINS; YOUNG ADULT;

EID: 77954487051     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01214.x     Document Type: Article

References (48)

1. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007 45 (2 507 539.
2. Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis 1991 163 (5 1138 1140.
3. Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995 23 (1 14 20.
4. Shire NJ, Rouster SD, Stanford SD et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2007 44 (3 309 314.
5. Baginski I, Chemin I, Hantz O et al. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion 1992 32 (3 215 220.
6. Thiers V, Nakajima E, Kremsdorf D et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988 2 (8623 1273 1276.
7. Campe H, Hillebrand GF, Mairhofer H, Nitschko H, Jager G. Undetected chronic hepatitis B virus infection of a vaccinated dialysis patient after liver transplantation. Nephrol Dial Transplant 2005 20 (7 1492 1494.
8. Kannangai R, Molmenti E, Arrazola L et al. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat 2004 11 (4 297 301.
9. Tamori A, Nishiguchi S, Kubo S et al. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection. J Med Virol 2003 69 (4 475 481.
10. Squadrito G, Pollicino T, Cacciola I et al. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 2006 106 (6 1326 1330.
11. Thio CL, Seaberg EC, Skolasky JR et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002 360 (9349 1921 1926.
12. Nunez M, Rios P, Perez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002 16 (15 2099 2101.
13. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998 17 (1 6 13.
14. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 2004 39 (1 51 57.
15. Raimondo G, Navarra G, Mondello S et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008 48 (5 743 746.
16. Hu K-Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002 9 (4 243 257.
17. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 2004 127 (5 1356 1371.
18. Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol 2006 78 (1 53 59.
19. Hass M, Hannoun C, Kalinina T, Sommer G, Manegold C, Günther S. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 2005 42 (1 93 103.
20. Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 2002 35 (5 1215 1224.
21. Kao J-H, Chen P-J, Lai M-Y, Chen D-S. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol 2002 68 (2 216 220.
22. Schories M, Peters T, Rasenack J. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 2000 33 (5 799 811.
23. Wagner AA, Denis F, Weinbreck P et al. Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS 2004 18 (3 569 571.
24. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000 81 (5 1165 1174.
25. Shire NJ, Rouster SD, Rajicic N, Sherman KE. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004 36 (3 869 875.
26. Gerken G, Kremsdorf D, Capel F et al. Hepatitis B defective virus with rearrangements in the PreS gene during chronic HBV infection. Virol 1991 183 (2 555 565.
27. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997 25 (24 4876 4882.
28. Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol 2002 83 (6 1267 1280.
29. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986 3 (5 418 426.
30. Kumar S, Tamura K, Nei M. MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004 5 (2 150 163.
31. Fung SK, Lok ASF. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 2004 40 (4 790 792.
32. Stuyver LJ, Locarnini SA, Lok A et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001 33 (3 751 757.
33. Korber B, Meyers G. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses 1992 8 (9 1549 1560.
34. Bock CT, Tillmann HL, Torresi J et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 2002 122 (2 264 273.
35. Chu C-J, Keeffe EB, Han S-H et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003 125 (2 444 451.
36. Moriya T, Kuramoto IK, Yoshizawa H, Holland PV. Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit. J Clin Microbiol 2002 40 (3 877 880.
37. Stuyver L, De Gendt S, Van Geyt C et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000 81 (1 67 74.
38. Chudy M, Schmidt M, Czudai V et al. Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology 2006 44 (1 99 107.
39. Kato H, Orito E, Gish RG et al. Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G. Hepatology 2002 35 (4 922 929.
40. Amini-Bavil-Olyaee S, Alavian S-M, Adeli A et al. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J Med Virol 2006 78 (3 358 364.
41. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY. Molecular evolution of hepatitis B virus over 25 years. J Virol 2006 80 (21 10307 10314.
42. Torres-Puente M, Bracho MA, Jimenez N, Garcia-Robles I, Moya A, Gonzalez-Candelas F. Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J Gen Virol 2003 84 (9 2343 2350.
43. Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 1990 64 (2 613 620.
44. Jeantet D, Chemin I, Mandrand B et al. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 2004 73 (4 508 515.
45. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 2004 4 : 159 162.
46. Lin X, Yuan Z-H, Wu L, Ding J-P, Wen Y-M. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol 2001 75 (23 11827 11833.
47. Bruss V, Ganem D. Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J Virol 1991 65 (7 3813 3820.
48. Xu Z, Jensen G, Yen TS. Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol 1997 71 (10 7387 7392.